| 03/04/2025 |
6-K |
SHL discloses write-offs and extraordinary items for full year results 2024 |
|
| 24/03/2025 |
6-K |
SHL acquires remaining stake of Mediton Group |
|
| 11/03/2025 |
6-K |
SHL Telemedicine Ltd. to delist its ADRs from Nasdaq and terminate its U.S. ADR program and SEC reporting obligations |
|
| 04/02/2025 |
6-K |
SHL appoints Lior Haalman as new CFO |
|
| 10/12/2024 |
6-K |
SHL announces Special General Meeting Results |
|
| 05/11/2024 |
6-K |
SHL announces invitation to a Special General Meeting |
|
| 26/09/2024 |
6-K |
SHL announces half-year results 2024 |
|
| 24/09/2024 |
6-K |
SHL to acquire remaining stake of Mediton |
|
| 19/09/2024 |
6-K |
Invitation to half-year results 2024 conference call |
|
| 05/09/2024 |
6-K |
SHL announces Special General Meeting Results |
|
| 03/09/2024 |
6-K |
SHL Telemedicine to appoint Dr. Itamar Offer as Chairman of the Company’s Board of Directors |
|
| 26/08/2024 |
6-K |
SHL Telemedicine’s Chairman announced he is stepping down |
|
| 02/08/2024 |
6-K |
SHL Telemedicine’s Chairman intends to step down in the near term |
|
| 31/07/2024 |
6-K |
Notice and Proxy Statement for the Special General Meeting |
|
| 29/07/2024 |
6-K |
SHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine |
|
| 25/07/2024 |
20-F/A |
Amendment No. 1 on Form 20-F/A – Annual Report |
|
| 20/06/2024 |
6-K |
SHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity |
|
| 09/05/2024 |
6-K |
SHL announces Special General Meeting Results |
|
| 18/04/2024 |
20-F |
Form 20-F |
|
| 17/04/2024 |
6-K |
SHL Telemedicine Ltd Announces the filing of Full-Year 2023 Results |
|
| 26/03/2024 |
6-K |
Notice and Proxy Statement for the Special General Meeting |
|
| 14/03/2024 |
6-K |
SHL announces change in CEO position |
|
| 08/02/2024 |
6-K |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
|
| 05/02/2024 |
6-K |
Update regarding upcoming Annual General Meeting – Change in the Composition of the Board of Directors |
|
| 28/12/2023 |
6-K |
Notice and the Proxy Statement for the Annual General Meeting |
|
| 21/09/2023 |
6-K |
SHL Telemedicine Ltd. Announces the Filing of its half year report 2023 |
|
| 23/06/2023 |
6-K |
REPORT PURSUANT TO RULE 13A-16 OR 15D-16 |
|
| 11/06/2023 |
S-8 |
REGISTRATION STATEMENT |
|
| 15/05/2023 |
6-K |
SHL Telemedicine Ltd. Announces the Filing of its Annual Report on Form 20-Ffor Fiscal Year 2022 |
|
| 12/05/2023 |
20-F/A |
ANNUAL REPORT PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 |
|
| 11/05/2023 |
20-F |
ANNUAL REPORT PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 |
|
| 11/05/2023 |
6-K |
Annual Report to Shareholders for the year ended December 31, 2022 filed with the SIX Swiss Exchange |
|
| 11/05/2023 |
6-K |
Press Release and investor presentation 2022 fiscal year annual results |
|
| 08/05/2023 |
6-K |
Notice and the Proxy Statement for the Special General Meeting |
|
| 28/04/2023 |
12b-25 |
FORM 12b-25 |
|
| 17/04/2023 |
6-K |
SHL Telemedicine publishes its Annual Report on 11 May 2023 |
|
| 04/04/2023 |
6-K |
SHL Telemedicine strengthens leadership of its German operation |
|
| 03/04/2023 |
6-K |
BARMER to launch new marketing activities for the Doctors’ Virtual Visits, Telehealth and other digital services via the BARMER Teledoktor App |
|
| 31/03/2023 |
6-K |
SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol “SHLT” |
|
